The Bristol ‘OA500 study’: progression and impact of the disease after 8 years  by Dieppe, P. et al.
Osteoarthritis and Cartilage (2000) 8, 63–68
© 2000 OsteoArthritis Research Society International 1063–4584/00/020063+06 $35.00/0
doi: 10.1053/joca.1999.0272, available online at http://www.idealibrary.com onThe Bristol ‘OA500 study’: progression and impact of the disease after
8 years
P. Dieppe*, J. Cushnaghan†, M. Tucker, S. Browning and L. Shepstone‡
Rheumatology Unit, University of Bristol Division of Medicine, Bristol Royal Infirmary, Bristol BS2 8HW, U.K.
Summary
Objective: To study the natural history of peripheral joint osteoarthritis (OA) and assess its impact over eight years in a prospective study of
500 patients.
Methods: 500 consecutive patients with peripheral joint OA were recruited from a hospital-based rheumatology clinic. All were invited for
review 3 and 8 years after entry. Joint sites involved, pain severity, change in index joints, global change in the condition, use of medication,
surgery and walking aids were all recorded at each visit, and after eight years disability was assessed by the health assessment
questionnaire (HAQ) and anxiety and depression by the Hospital anxiety and depression scale (HAD).
Results: At eight-year review, 349 patients were seen: 90% of those remaining alive. Outcome was heterogeneous. Sixty patients (17.2%)
reported worsening in all three subjective parameters (pain, index joint and global change) compared with 22 (6.3%) who improved in all
three parameters. Using this definition of worsening or improvement, strong baseline predictors of clinical outcome did not emerge. For
further description, the group was split according to the index joint sites involved at entry to the study, there being 111 with knee OA alone,
87 with hand and knee OA, 72 with hand disease alone, and 29 with hip disease alone. Forty-four percent of those with lone hand disease
at entry had acquired significant knee or hip OA 8 years later. The mean HAQ and HAD scores at 8 years were high, especially in those with
knee disease, indicating significant disability as a result of the disease. Those with knee or knee and hand disease had the worst outcome
in all parameters recorded. The data showed a general decrease in use of NSAIDs over the eight years, but an increase in utilization of
analgesics, surgery (especially for hip disease) and walking aids.
Conclusions: Patients with peripheral joint OA of sufficient severity to lead to hospital referral have a heterogeneous, but generally bad
outcome over 8 years, the disease resulting in high levels of physical disability, anxiety and depression, with a high level of utilization of
healthcare resources, including joint replacement, drugs and walking aids. The results were consistent with previous suggestions that
peripheral joint OA in older people is characterized by the slow acquisition of new joint sites. Progression and outcome may depend on a
complex set of psychosocial factors, as well as biological ones. © 2000 OsteoArthritis Research Society International
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Osteoarthritis (OA) is a common condition, often said to be
one of the main causes of pain and disability in older
people, and the most frequent of the rheumatic diseases.1,2
However, until recently, relatively little was known either
about the natural history of the condition, or the impact of
the disease on individuals. To address this problem, and to
see if subsets of the disease could be clearly defined, the
‘Bristol OA500 study’ was established in the late 1980s.3,4
It describes a prospective cohort of 500 people with periph-
eral joint osteoarthritis, ascertained through a hospital-
based rheumatology clinic. The basic demography of the
group has been described,3 3-year follow-up data63reported,4 and the radiographic progression of knee joint
OA in people in this cohort has been presented.5 The data
obtained from the cohort have contributed to the growing
body of information that suggests that OA subsets are best
defined according to the main joint site(s) affected.3,6
We here report the clinical outcomes of a proportion of
this cohort after eight years of study, according to the main
site(s) involved at entry. The data reported in this paper are
clinical, and largely concerned with the impact of the
condition on people, use of medical resources, acquisition
of new joint sites of involvement and intercurrent disease,
as well as possible predictors of outcome. Radiographic
data, and more detailed clinical findings on the knee and
hand joints (the most commonly affected sites) will be
submitted for publication elsewhere.Received 12 April 1999; accepted 10 September 1999.
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As reported previously, 500 consecutive patients with
peripheral joint OA were recruited from a hospital-based
rheumatology clinic.3 Three and 8 years later all patients
were invited to attend a follow-up clinic, and they were
re-examined by one of two observers (JC or MT). Infor-
mation obtained in the same way at each visit (0, 3 and
8 years) included self-reported pain severity (none, mild,
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(better, same, worse), and reported change in the overall
condition of their osteoarthritis (better, same or worse than
when first seen), use of analgesics or non-steroidal anti-
inflammatory drugs (NSAIDs), any surgery for their arthritis,
the use of walking aids, and the main joint sites with OA.
At each visit, an attempt was made to record which
peripheral joints were worst affected by osteoarthritis (no
attempt was made to assess spinal disease). When the
cohort was first seen, radiographs of all painful joints were
obtained and PAD classified one or two joint sites as the
‘index’ joints on the basis of their being the joints with
both radiographic evidence of definite OA (Kellgren and
Lawrence grade 2 or more) and identified by the patient
as causing the most problems. They were then interviewed
and examined fully by a single observer (JC). At the
subsequent 3 and 8 year reviews, JC or MT recorded the
three worst affected joint sites through a combination of
identification of those sites by the patient as causing
use-related pain which also had physical signs consistent
with a diagnosis of OA (crepitus and bony swelling at the
knee, Hebereden’s nodes on two or more distal inter-
phalangeal joints, or painful restriction of internal rotation at
the hip). Radiographs were not used to classify the joint
sites affected at 3 and 8 year visits, and no more specific
criteria were applied. Cases were then analyzed by ‘index
joint’ at baseline.
In addition to this longitudinal data, other cross-sectional
data was obtained at the 8-year review to assess outcome.
All patients seen at that time point filled in both the health
assessment questionnaire (HAQ, 7), and hospital anxiety
and depression scale (HAD, 8), and they were also asked
about any intercurrent diseases.STATISTICAL ANALYSIS
A chi-squared test was used to test for an association
between patient reported outcomes (better, same, worse)
and categorical baseline variables and an analysis of
variance was used to test for differences in continuous
variables with respect to patient reported outcomes. To test
for differences in reported pain and global change at
different time points in the different patient groups, the
Kruskal-Wallis test was used.
A chi-squared test was used to look for between group
differences in the numbers of patients using different health
care resources, and a one way analysis of variance for
differences in the health status of the different groups at 8
years.Results
At entry, the cohort consisted of 342 women (mean age
65.3 years) and 158 men (mean age 59.7). The most
commonly involved sites were the knees, hands and hips,
hip disease standing out as being present in a younger,
predominantly male group in comparison with other joint
sites.3 The mean disease duration reported by patients at
entry was 9.8 years (range 1–23). After 3 years, 415 of the
original cohort were available for review, and an overall
worsening of pain and disability were reported.4
After 8 years we were able to review a total of 349 of
the original 500 patients (70%), the remaining 151 either
having died (113=22.6%), been lost to follow-up (30=6%),
or refused to take part (8=1.6%). The only difference inbaseline demographic data between those who had died or
were lost to follow up and the whole group was in age, the
349 available for follow up being significantly younger at
entry than the remainder. Those available for follow-up
included 241 women and 108 men, and their worst reported
joint at follow up was: knee 149 (43.1%), hand 72 (20.8%),
hip 39 (11.3%), others (including spine) in 86 (24.9%) (data
missing in 3 cases). Overall global worsening of the con-
dition over eight years was reported in 216 compared with
62 who said that their arthritis was the same as eight years
previously, and 67 (19.4%) who claimed that it had
improved.
The three subjective indices of change over 8 years
(change in pain, change in index joints and global change)
were then combined in an attempt to define which patients
clearly improved or worsened over the 8 years. This
overall measure of change, which was predetermined, is
described as the ‘primary outcome measure’ in the remain-
der of this manuscript. Twenty-two (6.3%) described
improvement in the primary outcome measure, compared
with 60 (17.2%) who described worsening. In the remainder
there were many different discrepancies in change in these
three measures. Discussions with patients and the metrolo-
gists (JC and MT) suggest that there was great variation in
pain, in particular over time.
Several baseline variables were examined as possible
predictors of change in the primary outcome measure.
There were no statistically significant relationships (at the
5% level) between outcome and sex, occupation at entry
(either repetitive, non-manual, light manual or heavy
manual), hypertension, family history of OA, the presence
of rheumatoid factor, worst joint affected (as described
above), age, and body mass index. A statistically significant
association was found with respect to drug usage at
baseline (P=0.017). Those patients using NSAIDS at entry
were more likely to report an improvement than those that
were not (approximately 24% compared to 12%). A signifi-
cant relationship was also found between disease duration
and patients reported outcome (P=0.007). Patients report-
ing a worsening in their condition had, on average, a
disease duration of approximately five years greater than
those patients that reported an improvement.
The data set was then examined to allow a comparison
of outcome and change in patient groups, defined by the
index joint site(s) affected at entry, to allow a clear descrip-
tion of what happened to these patients, according to the
most widely accepted and clinically useful means of
describing subsets of the condition. The main patterns at
entry were lone involvement of one or both knees, hands or
hips, and the combination of hand and knee disease3—and
these are the patterns that have been included in the
subsequent data (the very small number of patients whose
main problem affected another joint, such as the ankle or
elbow, have been omitted from this analysis).
Of the 349 patients who were seen after eight years, 299
fitted into one of the four defined patterns of disease
distribution at entry, and had data recorded at entry and
three years (Table I). This represents 59% of the original
cohort of 500, or 77.3% of the 387 remaining alive at the
time of the 8-year review. At entry, 111 (37%) had OA of one
or both knees only, 87 (29%) had OA in both their knees
and hands, 72 (24%) had hand disease only (interphalan-
geal joints, thumb base, or both), and 29 (10%) had
isolated OA in one or both hips. The demographic data
shown on these patients shows that, as expected from the
entry data, those with hip disease were younger and had a
greater male preponderance than the other three groups.
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Demographic data on the 299 patients with common patterns of
joint involvement at entry and full clinical data available at entry,
3 and 8 years









Number 111 72 29 87
% female 59% 86% 9% 86%
Age at entry 60 59 50 64
Mean (SD) 10.7 9.4 12.1 9.3Table II
Reported changes in pain and overall condition at 3 and 8 years for each group as defined by index joint at












Entry None 5 (5%) 7 (10%) 2 (7%) 3 (3%)
Mild 39 (35%) 29 (41%) 14 (48%) 20 (23%)
Moderate 39 (35%) 28 (39%) 9 (31%) 33 (38%)
Severe 28 (25%) 7 (10%) 4 (10%) 30 (35%)*
3-Year None 4 (4%) 3 (5%) 1 (4%) 2 (2%)
Mild 29 (28%) 25 (40%) 14 (50%) 18 (22%)
Moderate 54 (51%) 29 (46%) 9 (32%) 38 (46%)
Severe 18 (17%) 6 (10%) 4 (14%) 24 (29%)*
8-Year None 3 (3%) 6 (8%) 1 (3%) 2 (2%)
Mild 27 (25%) 26 (36%) 10 (34%) 9 (10%)
Moderate 50 (45%) 27 (38%) 14 (48%) 43 (50%)
Severe 30 (27%) 13 (18%) 4 (14%) 32 (37%)*
Reported change
3-Year Better 26 (25%) 15 (23%) 11 (39%) 13 (16%)
Same 28 (27%) 18 (28%) 5 (18%) 13 (16%)
Worse 51 (49%) 31 (48%) 12 (43%) 56 (68%)†
8-Year Better 22 (20%) 19 (27%) 6 (21%) 12 (14%)
Same 19 (17%) 14 (20%) 7 (25%) 13 (15%)
Worse 69 (63%) 38 (54%) 15 (54%) 60 (71%)
*P<0.005, †P<0.05 (Kruskal–Wallis test).Change in pain and global rating of the osteoarthritis by
the patients is shown in Table II. Those with combined knee
and hand disease at entry reported significantly greater
intensities of pain at all times than other groups, and
appeared to show more worsening of the condition as well.
The data also indicate a steady deterioration in the groups
overall, with those with knee involvement (either lone or in
combination with the hand) faring worse.
Table 3 shows some of the data on the use of drugs
(analgesics and NSAIDs), walking aids, and surgical inter-
ventions for OA in the four groups of patients. There was an
overall trend to less use of NSAIDs and greater depen-
dence on simple analgesics, but a steady rise in the need
for walking aids, and the provision of surgical interventions,
even in those with lone hand disease at entry. This may be
related to the acquisition of OA in lower limb joints,
because, as shown in Table IV, 44% of those with lone
hand disease had apparently acquired significant knee or
hip OA 8 years later. Table III also shows that a much
higher proportion of those with hip disease came to surgery
than those with knee involvement and that those with lone
hip disease used significantly less drugs than those with
knee or knee and hand disease. It appears from Table 4that as many of those with lone knee OA at entry developed
hand disease after 8 years (33%) as vice-versa, and that an
even higher percentage of those with lone hip disease at
entry developed knee disease subsequently (45%), how-
ever, it must also be noted that a separate analysis to look
for evidence of acquisition of new joint sites between the 3-
and 8-year observation time points showed no statistical
evidence of this trend, so the data presented in Table IV
could be due to the different criteria used to assess joint
involvement at entry and 8 years.
Those patients in the lone knee OA group that had knee
replacement surgery in the 8-year follow up period did not
show any significant improvement either in self reported
pain or in the primary outcome measure when compared
with those that did not have surgery. Of those that had
surgery, 70% reported a worsening of their condition com-
pared with 61% that did not have surgery; 26% reported no
or mild pain at eight years compared with 27% that did not
have surgery. A similar relative lack of improvement in the
primary outcome measure was shown in those patients
with lone hip OA that had hip replacement surgery over the
eight year follow up period. However, this was based on a
relatively small sample.
The mean HAQ score was greater than one in all groups
at 8 years, except for those with lone hand disease at entry
(Table V). The recorded HAD scores also suggest that
many of the patients in this study were suffering from a lot
of anxiety, depression, or both when the follow-up data
were collected. Those with a combination of knee and hand
disease at entry had significantly higher HAQ and HAD
(depression) scores at 8 years than those in any of the
other groups.
Some of the reported disability and use of interventions
such as walking aids could be related to ageing and
intercurrent disease, rather than OA. We therefore
enquired about intercurrent disease. There was a high
66 P. Dieppe et al.: Eight-year prospective study of OAprevalence of co-morbid conditions, over 30% of older
patients complaining of cardiovascular, respiratory or gas-
trointestinal disorders, but we could find no differences
between groups.Table III
Numbers of patients in each group using drugs (analgesics or NSAIDs), walking aids, or coming to surgery for










Number using walking aids
Entry 36 (33%) 2 (3%) 9 (32%) 23 (27%) 70
3-Year 47 (45%) 3 (5%) 8 (29%) 34 (41%) 92
8-Year 70 (63%) 13 (18%) 12 (41%) 53 (61%) 148
Number using drugs
Entry
Analgesic 40 (36%) 21 (30%) 15 (52%) 35 (41%) 111
NSAIDs 61 (55%) 41 (58%) 13 (45%) 52 (61%) 167
3-Year
Analgesic 64 (61%) 24 (38%) 12 (43%) 51 (62%) 151*
NSAIDs 50 (48%) 23 (37%) 10 (36%) 43 (52%) 126
8-Year
Analgesic 64 (59%) 39 (54%) 13 (45%) 65 (75%) 181*
NSAIDs 56 (51%) 21 (29%) 11 (38%) 31 (36%) 119
Surgery
By 3-year 15 (14%) 5 (8%) 9 (32%) 17 (21%) 46
By 8-year 36 (33%) 13 (18%) 14 (48%) 30 (34%) 93
*Chi-square test shows significantly less analgesic use in patients with hip disease than in those with knee or
knee and hand disease (P<0.01).Table IV
Numbers (%) of patients reporting osteoarthritis at additional sites after 8 years









Additional joint sites (by 8-year visit)
Knees — 24 (33%) 13 (45%) —
Hips 20 (18%) 8 (11%) — 15 (17%)
Hands 36 (33%) — 7 (24%) —Discussion
Most studies reporting on the natural history of OA have
been concerned with radiographic rather than clinical
change,9,10,11 and studies of the impact of the condition in
terms of disability or quality of life have mostly studied
groups before and after surgical intervention.12,13 However,
from the patient’s point of view it is obvious that pain,
disability and quality of life are more important than radio-
graphic outcome, and the data that we reported after three
years of follow-up of this cohort showed a discrepancy
between radiographic and clinical change, indicating that it
may be inappropriate to use radiographic changes as a
surrogate for patient outcomes in OA.4 In this report we
have concentrated therefore, on the clinical changes in this
group of patients, there being virtually no comparable
published data on the outcome of osteoarthritis in patients
whose condition is sufficiently severe to lead to referral to a
hospital based rheumatology clinic. The main conclusion
that can be drawn from the outcome of the group as a
whole is that peripheral joint OA is a condition that causespersistent but variable pain, and severe disability in many
patients. However, the clinical outcome is obviously very
heterogeneous, some patients reporting improvement.
Reported improvement could be due to the ability of some
patients to adapt better to the condition over time, or to
changing needs and aspirations, rather than genuine
improvement in disease, and the data presented does not
allow us to speculate on the cause.
The variability of self-reported changes in pain, index
joint condition and global assessment were striking; most
patients showing no consistent change over time; and only
a minority reporting either improvement or worsening on
our chosen primary outcome measure. This is consistent
with other recent data that suggest that pain and disability
are as dependent on psychosocial variables as they are on
the condition of the joint14,15 and would imply that the
assessment of impact at any single time point will always
be clouded by other dependent variables, such as social
isolation, which are not recorded in this study, and gener-
ally ignored in the assessment of OA,16 as well as vari-
ations in adaptation and illness related behaviours.17,18 We
also acknowledge the fact that review at an arbitrary time
point 8 years after entry to the study might not reflect what
is going on over the whole time period of the study.
One of our main aims when first setting up this study,
was to find factors that might predict the outcome, but few
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The impact of disease on the four groups of patients described, as












Mean 1.32 0.84 1.07 1.60
Std dev. 0.77 0.73 0.76 0.78*
HAD (anxiety)
Mean 7.23 6.29 7.90 7.57
Std dev. 4.22 4.24 4.89 4.57
HAD (depression)
Mean 5.81 4.31 5.59 5.46
Std dev. 3.78 3.41 3.31 3.39†
One way ANOVA tests showed that those with knee or knee and
hand disease were significantly more disabled (*P=0.0001) and
depressed (†P=0.05) than other groups.such factors have emerged clearly either from the three
or eight year data. However, we accept that the chosen
outcome measures in this study were crude, limiting our
ability to detect predictors. It is interesting to note the
negative findings; there being no association between age,
sex, occupation or body mass index and change in the
primary outcome measure for example; the apparent dis-
crepancy between this finding and some other data might
be in part due to the fact that we were concentrating on
clinical, rather than radiographic changes. The fact that
patients with a longer disease duration were more likely to
report worsening probably reflects the slowly progressive
nature of the condition, which is apparent from other data
in this study (addition of new joint sites). The only other
association found, that those taking non-steroidal anti-
inflammatory drugs (NSAIDs) at entry were more likely to
report improvement is difficult to interpret, but would sug-
gest that NSAIDs usage should not be considered as
necessarily deleterious to the progression of the arthritis.
The chief, negative conclusion that we have to make from
this part of the study is that the key causes and predictors
of the heterogeneity of outcome for patients with osteoar-
thritis of their peripheral joints remain largely unexplained,
and should be studied further. However, a further important
caveat to this conclusion is the size of the study, as it may
not have the power to detect some associations between
baseline factors and outcomes, particularly as relatively
small numbers clearly got better or worse.
After 8 years of follow-up, some of the conclusions that
we came to from the previous cross-sectional study of
this cohort appear to have been substantiated. The
co-existence of hand and knee disease, and the important
observation that peripheral joint OA is characterized by the
slow acquisition of new joint sites over time, inferred from
the first cross-sectional report3 has again been suggested
by these data. However, the ways in which the presence or
absence of OA was defined in this study presents a major
limitation to this interpretation—the change in methods and
change in observers over time could have affected classi-
fication of joints as having or not having OA. When the
study was first established there were no published clinical
criteria for the definition or classification of OA, and
although the clinical definitions used in the 3 and 8 year
follow-up are consistent with the ACR criteria,19 the lack offormal standardization of the observations means that the
findings presented in Table 4 must be interpreted with great
caution.
The main new conclusions that can be drawn from the
8-year data, analyzed according to the main joint sites
affected at entry, are: (1) that those with knee disease
(either with or without hand disease) became more dis-
abled and were more likely to suffer severe pain than those
with lone hip or hand disease at entry, and that they were
using more drugs and walking aids than the other groups;
(2) that those with hip disease were more likely to come to
surgery than those with knee disease, in spite of less pain
and disability than the knee group; (3) that over the 8 years
there has been a trend to less use of NSAIDs and more use
of simple analgesics; (4) that the overall impact of the
disease is very great in terms of the overall degree of both
physical and psychological disability, as well as the use of
drugs and walking aids, and that most of this impact is likely
to be due to the OA.
We were interested by the finding that although surgery
was more likely to be for hip replacement than knee
replacement, those with knee disease appeared to have
considerably more pain and disability after 8 years than the
younger patients with hip disease. There are many possible
reasons for this, including age, intercurrent diseases and
OA at other joint sites. We also accept that the inclusion of
those who had undergone surgery during the study in the
final analyses could be a source of criticism.
We elected to analyze the data according to the main
joint site(s) affected at entry because this is the most
conventional and clinically valuable means of subsetting
patients with peripheral joint OA6 of immediate and obvious
relevance to those providing health services, as well as
those who have the condition. Our ability to hold this cohort
together (thanks largely to SB) meant that relatively large
numbers were available for data analysis at all three time
points within the four main patterns of OA described in the
first report. Furthermore, the fact that we were able to
review 90% of those remaining alive at the time of the
8-year review (349 of the 387 patients) reduces the likeli-
hood of our results being affected by loss of those with
the most severe disability or other confounding factors.
Caveats to the interpretation of the data include the fact
that it is essentially an observational study of a highly
selected group of patients, we also recognize that the
numbers in the subgroups are relatively small, particularly
those with hip disease. In addition, over the 8 years that we
have followed these patients they have aged, acquired OA
at new joint sites and developed intercurrent diseases. As
we have no control or comparator group in the study, we
cannot be certain about how much of their significant
burden of pain, disability, anxiety and depression is due to
these other factors, rather than to their osteoarthritis. We
chose the HAQ and HAD as ways of assessing the out-
come in terms of burden of physical or psychological
disability respectively, as these are standard measures,
widely used. The scores (in each case a higher score
means more disability) for physical disability, anxiety and
depression are all much higher than that which would be
expected in such an age group.7,8 Furthermore, the mean
scores for the HAQ were >1 in all except the hand alone
group, indicating significant levels of physical disability, and
the high use of walking aids and surgery for OA suggest
that arthritis was the main cause of these patient problems.
It is unfortunate that HAQ and HAD scores were not
available at entry for comparisons with outcomes, as some
68 P. Dieppe et al.: Eight-year prospective study of OAof the differences in the groups at 8 years could simply
reflect different levels of severity at ascertainment.
In spite of relatively small numbers, the greater utilization
of hip rather than knee surgery is a cause for concern, as it
does not appear to relate to disease severity or impact.
This tends to support the conclusions of Tennant et al.,20
and of the US PORT (patient outcomes research team)
study on knee OA,21 both of which suggest that knee
surgery is an under-utilized intervention for knee OA. We
are currently examining possible reasons for this.22 The
trend for less use of NSAIDs in patients for OA reflects
national trends over the last few years23 but may be higher
than expected in part due to the attempts of some local
consultants (including PAD) to reduce NSAID usage in this
patient group.24
We have acknowledged here and previously that this
study has many limitations including both the potential for
our group to be unrepresentative, and the uncontrolled
observational nature of our data. Nevertheless, we believe
that many of the conclusions reached are likely to be
generalizable, and that the data adds to our understanding
of the natural history of OA and its very high impact of the
disorder on many people’s lives. The data supports the
case of those who argue that osteoarthritis is an important
disease because of its continuing burden of pain, disability
and healthcare utilization over a period of many years, and
it confirms that fact that people with advanced osteoarthritis
at any of the major joint sites are likely to acquire disease at
other sites with time, often leading to the need for surgical
intervention. However, these data and our previous pro-
spective reports also re-emphasize the heterogeneity of the
clinical outcomes of OA, and suggest that it is dependent
on complex psychosocial factors as well as biological ones.
When considering the outcome of a chronic disease
of older people a biopsychosocial model may be more
appropriate than a simple biological one.Acknowledgments
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